Arthritis Research & Therapy

official impact factor 4.36

Highly Access

Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus

Petar S Lenert

Arthritis Research & Therapy 2006, 8:203 doi:10.1186/ar1888

Accesses  

  • Last 30 days: 48 accesses
  • Last year: 823 accesses
  • All time: 9588 accesses

Cited by

BioMed Central: 4 citations

Editorial   Free

Inhibitory short synthetic oligodeoxynucleotides and lupus

Zheng Liu, Anne Davidson Arthritis Research & Therapy 2009, 11:116 (26 June 2009)

Research article   Open Access

DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Faslpr/lpr mice in vivo

Petar Lenert, Kei Yasuda, Liliana Busconi, Patrice Nelson, Courtney Fleenor, Radhika S Ratnabalasuriar, Peter L Nagy, Robert F Ashman, Ian R Rifkin, Ann Marshak-Rothstein Arthritis Research & Therapy 2009, 11:R79 (28 May 2009)

Review   Free

Toll-like receptors and innate immune responses in systemic lupus erythematosus

Robert Lafyatis, Ann Marshak-Rothstein Arthritis Research & Therapy 2007, 9:222 (29 November 2007)

Review   Free

Developments in lupus 2006

Arne Hansen, Falk Hiepe, Thomas Dörner Arthritis Research & Therapy 2007, 9:215 (11 July 2007)